Emory University regulatory update

Emory received U.S. Patent No. 5,539,116 covering 3TC. Epivir 3TC was developed by BioChem Pharma Inc. (BCHXF, Laval, Quebec) and is sold by Glaxo Wellcome. Emory filed suit against BCHXF and Glaxo...